13 results on '"Michael, Eva"'
Search Results
2. Long term treatment with ataluren—the Swedish experience
- Author
-
Michael, Eva, Sofou, Kalliopi, Wahlgren, Lisa, Kroksmark, Anna-Karin, and Tulinius, Már
- Published
- 2021
- Full Text
- View/download PDF
3. NFL is a marker of treatment response in children with SMA treated with nusinersen
- Author
-
Olsson, Bob, Alberg, Lars, Cullen, Nicholas C., Michael, Eva, Wahlgren, Lisa, Kroksmark, Anna-Karin, Rostasy, Kevin, Blennow, Kaj, Zetterberg, Henrik, and Tulinius, Már
- Published
- 2019
- Full Text
- View/download PDF
4. Spermidine protects from age-related synaptic alterations at hippocampal mossy fiber-CA3 synapses
- Author
-
Maglione, Marta, Kochlamazashvili, Gaga, Eisenberg, Tobias, Rácz, Bence, Michael, Eva, Toppe, David, Stumpf, Alexander, Wirth, Alexander, Zeug, André, Müller, Franziska E., Moreno-Velasquez, Laura, Sammons, Rosanna P., Hofer, Sebastian J., Madeo, Frank, Maritzen, Tanja, Maier, Nikolaus, Ponimaskin, Evgeni, Schmitz, Dietmar, Haucke, Volker, and Sigrist, Stephan J.
- Published
- 2019
- Full Text
- View/download PDF
5. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)—study protocol for a randomized controlled trial
- Author
-
Wirth, Miranka, Schwarz, Claudia, Benson, Gloria, Horn, Nora, Buchert, Ralph, Lange, Catharina, Köbe, Theresa, Hetzer, Stefan, Maglione, Marta, Michael, Eva, Märschenz, Stefanie, Mai, Knut, Kopp, Ute, Schmitz, Dietmar, Grittner, Ulrike, Sigrist, Stephan J., Stekovic, Slaven, Madeo, Frank, and Flöel, Agnes
- Published
- 2019
- Full Text
- View/download PDF
6. Long-term follow-up and characteristic pathological findings in severe nemaline myopathy due to LMOD3 mutations
- Author
-
Michael, Eva, primary, Hedberg-Oldfors, Carola, additional, Wilmar, Philip, additional, Visuttijai, Kittichate, additional, Oldfors, Anders, additional, and Darin, Niklas, additional
- Published
- 2019
- Full Text
- View/download PDF
7. Nusinersen versus sham control in later-onset spinal muscular atrophy
- Author
-
Vogt, Sibylle, Krueger, Marcus, Pechmann, Astrid, Rippberger, Bianca, Eckenweiler, Matthias, Schara, Ulrike, Koelbel, Heike, Andres, Barbara, Rupprich, Katrin, Gangfuss, Andrea, Jachertz, Philipp, Della Marina, Adela, Sponemann, Nina, Pane, Markia, Palermo, Concetta, Piastra, Marco, Fanelli, Lavinia, de Sanctis, Roberto, Genovese, Orazio, Antonaci, Laura, Pera, Maria Carmela, Lamendola, Priscilla, Messina, Sonia, Vita, Gianluca, Di Bella, Vincenzo, Sframeli, Maria, Rosa, Matteo, Barcellona, Costanza, Distefano, Maria Grazia, Cavallaro, Filippo, Versaci, Antonio, de Luca, Francesco, Vita, Giuseppe, Nacimento Osorio, Andres, Tizzano, Eduardo, Ortez Gonzalez, Carlos Ignacio, Ortigoza Escobar, Juan Dario, Colomer Oferil, Juame, Medina Cantillo, Julita, Febrer Rotger, Anna, Vigo Morancho, Meritxell, Eldblom, Johanneh, Darin, Niklas, Kroksmark, Anna Karin, Lindstedt, Asa, Michael, Eva, Kimber, Eva, Wahlgren, Lisa, Chan, Sophelia Hoi-Shan, Chim, Stella, Chiu, Joseph, Ho, Alvin Chi Chung, Ip, Jing Kun Janice, Lam, Wendy Wai Man, Ng, Maggie Chui-San, Wan, Connie, Wong, Virginia Chun Nei, Yue, Yvonne, Arakawa, Reiko, Yamauchi, Akemi, Nagata, Satoru, Ito, Yasushi, Nakatsukasa, Hidetsugu, Takeshita, Akiko, Hirasawa, Kyoko, Ikai, Tetsuo, Eto, Kaoru, Otamni, Yui, Takeshima, Yasuhiro, Fukuda, Noroki, Tanaka, Yasuhiro, Shimomura, Hideki, Lee, Tomoko, Shibano, Takayuki, Mercuri, E., Tachikawa, Tomohiro, Darras, B. T., Chae, Jong-Hee, Chiriboga, C. A., Lim, Byung Chan, Day, J. W., Shin, Hyung-Ik, Campbell, C., Kim, Soo Yeon, Connolly, A. M., Choi, Sun Ah, Iannaccone, S. T., Son, Woo Sung, Kirschner, J., Jo, Hyemi, Kuntz, N. L., Chun, Seong Min, Saito, K., Kim, Hyuna, Shieh, P. B., Tulinius, M., Mazzone, E. S., Montes, J., Bishop, K. M., Yang, Q., Foster, R., Gheuens, S., Bennett, C. F., Farwell, W., Schneider, E., de Vivo, D. C., Finkel, R. S., Bradley, Walter G., Kaufmann, Petra, Dickson, Patricia I., Reingold, Stephen C., Davis, Charles S., Arredondo, Kristen, Castro, Diana, Cowie, Margaret, Farrow-Gillespie, Alan, Hebert, Andrew, Kauk, Melissa, Miller, Nancy, Nelson, Leslie, Spain, Thomas, Cappell, Joshua, Constantinescu, Andrei, Cruz, Rosangel, Dastgir, Jahannaz, de Vivo, Darryl, Dunaway, Sally, Engelstad, Kristin, Khandji, Alexander G., Kramer, Samantha, Marra, Jonathan, Popolizio, Molly, Salazar, Rachel, Weimer, Louis H., Aziz-Zaman, Sonya, Lamarca, Nicole, Ghosh, Partha, Al-Ghamdi, Fouad, Liew, Wendy, Graham, Robert, Berde, Charles, Sethna, Navil, Koka, Anjali, Wang, Luke, Laine, Regina, Souris, Michelle, Ordonez, Grace, Harrington, Timothy, Szelag, Heather, Pasternak, Amy, Mirek, Elizabeth, Quigley, Janet, Finkel, Richard, Berry, Debbie, Civitello, Matthew, Endsley, Julie Duke, Eden, Candace, Leon, Wendy, O'Reardon, Kathleen, Sigurdardottir, Laufey, Johnson, Craig, Turner, Jenna, Vega, Melisa, Weber-Guzman, Fabiola, Zinn, Matthias, Rocha, Ana Carolina Tesi, Watson, Karolina, d'Souza, Genevieve, Ramamurthi, R. J., Gee, Richard, Kitsuwa-Lowe, Janis, Hagerman, Katharine, Crasta, Sheela, Welsh, Lesly, Paulose, Shirley, Mcfall, Danielle, Perez, Jennifer, Patnaik, Swetapadma, Sanjanwala, Bharati, Sakamuri, Sarada, Proud, Crystal, Purse, Bona Park, Duong, Trinh Tina, Sampson, Jacinda, Tennekoon, Gihan, Brandsema, John, Glanzman, Allan, Flickinger, Jean, Toms, Michele, Adang, Laura, Stanford, Delores, Mayer, Oscar, Zigmont, Joshua, Chadehumbe, Madeline, Kichula, Elizabeth, Finanger, Erika, Russman, Barry, Roberts, Colin, Frank, Andrea, Benjamin, Danielle, Zilke, Kirsten, Golumbek, Paul T., Zaidman, Craig M., Anand, Pallavi, Gadeken, Rebecca, Siener, Catherine, Kuntz, Nancy, Epstein, Leon, Krueger, Jena, Goldman, Stewart, Krosschell, Kristin, Blomgren, Colleen, Choi, Hyoung Won, Kurz, Jonathan, Parsons, Julie, Janas, Joanne, Yang, Michele, Ballard, Alison, Carry, Terri, Shea, Stephanie, Bielsky, Alan, Booker, Kaylee, Camuto, Alicia, Lord-Halvorson, Sierra, Gibbons, Melissa, Zimmerman, Carl, Allen, Victoria, Fuhr, Peter, Johnson, Hannah, Tran, Vi, Vanderveen, Gina, Shieh, Perry, Fowler, Eileen, Parziale, Nicholas, Rao, Lekha, Skura, Christy, Kelley, Carolyn, Shu, Francy, Oskoui, Maryam, Zielinski, David, Poulin, Chantal, Ingelmo, Pablo Mauricio, Desilets, Sarah Turgeon, Dinunzio, Pamela, Rivera, Gonzalo, Srour, Myriam, Arpin, Stephanie, Goobie, Sharan, Gibson, Paul, Scholtes, Cheryl, Mcdonald, Wendy, Zapata, Eugenio, Nguyen, Cam-Tu Emilie, Servais, Laurent, Gargaun, Elena, Le Moing, Anne-Gaelle, Gidaro, Teresa, Vialle, Raphael, Guye, Marie-Laurence, Lilien, Charlotte, Olliver, Gwenn, Gilabert, Stephanie, Borell, Sabine, Wider, Sabine, Stein, Sabine, Universität Duisburg-Essen = University of Duisburg-Essen [Essen], Department of Paediatrics, Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma] (Unicatt), Vall d'Hebron University Hospital [Barcelona], CIBER de Enfermedades Raras (CIBERER), Handicaps génétiques de l'enfant (Inserm U393), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Seoul National University Hospital, Max-Planck-Institut für Mikrostrukturphysik (MPI-HALLE), Max-Planck-Gesellschaft, The University of Tokyo (UTokyo), Institut de Chimie Organique et Analytique (ICOA), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université d'Orléans (UO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Institute of Plasma Physics, Chinese Academy of Sciences (ASIPP), Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Laboratoire de mécanique des solides (LMS), École polytechnique (X)-Mines Paris - PSL (École nationale supérieure des mines de Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS), CureSMA [Elk Grove Village, IL, USA], Harvard Medical School [Boston] (HMS), Institute for Marine and Antarctic Studies [Hobart] (IMAS), University of Tasmania [Hobart, Australia] (UTAS), The Hospital for sick children [Toronto] (SickKids), University of Toronto, The Open University [Milton Keynes] (OU), Department of Pediatrics, Feinberg School of Medicine, Northwestern University [Evanston]-Northwestern University [Evanston]-Northwestern University, University Hospital Basel [Basel], McGill University Health Center [Montreal] (MUHC), Service de génétique [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau, Service of Clinical Trials and Databases, Institut de Myologie, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), CHU Amiens-Picardie, Groupe de Recherche sur l'Analyse Multimodale de la Fonction Cérébrale - UMR INSERM_S 1105 (GRAMFC), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University of Oxford, Schara, Ulrike (Beitragende*r), Koelbel, Heike (Beitragende*r), Rupprich, Katrin (Beitragende*r), Gangfuss, Andrea (Beitragende*r), Della Marina, Adela (Beitragende*r), and Sponemann, Nina (Beitragende*r)
- Subjects
0301 basic medicine ,Male ,[SDV]Life Sciences [q-bio] ,spinal ,Medizin ,Oligonucleotides ,Spinal Muscular Atrophies of Childhood ,Pediatrics ,law.invention ,Age of Onset ,Child ,Child, Preschool ,Double-Blind Method ,Female ,Humans ,Infant ,Injections, Spinal ,Least-Squares Analysis ,Motor Skills ,Oligonucleotides, Antisense ,Medicine (all) ,0302 clinical medicine ,age of onset ,Randomized controlled trial ,law ,Clinical endpoint ,inglese ,injections ,Motor skill ,motor skills ,General Medicine ,SMA ,Settore MED/26 - NEUROLOGIA ,medicine.anatomical_structure ,female ,Anesthesia ,Nusinersen ,Spinal ,antisense ,preschool ,Injections ,03 medical and health sciences ,least-squares analysis ,Settore MED/39 - NEUROPSICHIATRIA INFANTILE ,Settore MED/41 - ANESTESIOLOGIA ,medicine ,Antisense ,Preschool ,business.industry ,Spinal muscular atrophy ,Motor neuron ,medicine.disease ,030104 developmental biology ,Age of onset ,business ,030217 neurology & neurosurgery - Abstract
Background: Nusinersen is an antisense oligonucleotide drug that modulates pre–messenger RNA splicing of the survival motor neuron 2 (SMN2) gene. It has been developed for the treatment of spinal muscular atrophy (SMA). Methods: We conducted a multicenter, double-blind, sham-controlled, phase 3 trial of nusinersen in 126 children with SMA who had symptom onset after 6 months of age. The children were randomly assigned, in a 2:1 ratio, to undergo intrathecal administration of nusinersen at a dose of 12 mg (nusinersen group) or a sham procedure (control group) on days 1, 29, 85, and 274. The primary end point was the least-squares mean change from baseline in the Hammersmith Functional Motor Scale–Expanded (HFMSE) score at 15 months of treatment; HFMSE scores range from 0 to 66, with higher scores indicating better motor function. Secondary end points included the percentage of children with a clinically meaningful increase from baseline in the HFMSE score (≥3 points), an outcome that indicates improvement in at least two motor skills. Results: In the prespecified interim analysis, there was a least-squares mean increase from baseline to month 15 in the HFMSE score in the nusinersen group (by 4.0 points) and a least-squares mean decrease in the control group (by –1.9 points), with a significant between-group difference favoring nusinersen (least-squares mean difference in change, 5.9 points; 95% confidence interval, 3.7 to 8.1; P Conclusions: Among children with later-onset SMA, those who received nusinersen had significant and clinically meaningful improvement in motor function as compared with those in the control group. (Funded by Biogen and Ionis Pharmaceuticals; CHERISH ClinicalTrials.gov number, NCT02292537. opens in new tab.)
- Published
- 2018
- Full Text
- View/download PDF
8. A new method to characterize function of theDrosophilaheart by means of optical flow
- Author
-
Mönck, Hauke, primary, Toppe, David, additional, Michael, Eva, additional, Sigrist, Stephan, additional, Richter, Vincent, additional, Hilpert, Diana, additional, Raccuglia, Davide, additional, Efetova, Marina, additional, and Schwärzel, Martin, additional
- Published
- 2017
- Full Text
- View/download PDF
9. Spermidine protects against α-synuclein neurotoxicity
- Author
-
Büttner, Sabrina, Broeskamp, Filomena, Sommer, Cornelia, Markaki, Maria, Habernig, Lukas, Alavian-Ghavanini, Ali, Carmona-Gutierrez, Didac, Eisenberg, Tobias, Michael, Eva, Kroemer, Guido, Tavernarakis, Nektarios, Sigrist, Stephan J, and Madeo, Frank
- Subjects
Manganese ,dopaminergic neuron loss ,Spermidine ,Parkinson's disease ,Dopaminergic Neurons ,aging ,neurodegeneration ,Parkinson Disease ,Motor Activity ,Protective Agents ,Disease Models, Animal ,Cell Cycle News & Views ,α-synuclein ,Drosophila melanogaster ,Report ,Autophagy ,alpha-Synuclein ,Animals ,Humans ,Caenorhabditis elegans ,motor dysfunction - Abstract
As our society ages, neurodegenerative disorders like Parkinson`s disease (PD) are increasing in pandemic proportions. While mechanistic understanding of PD is advancing, a treatment with well tolerable drugs is still elusive. Here, we show that administration of the naturally occurring polyamine spermidine, which declines continuously during aging in various species, alleviates a series of PD-related degenerative processes in the fruit fly Drosophila melanogaster and the nematode Caenorhabditis elegans, two established model systems for PD pathology. In the fruit fly, simple feeding with spermidine inhibited loss of climbing activity and early organismal death upon heterologous expression of human α-synuclein, which is thought to be the principal toxic trigger of PD. In this line, administration of spermidine rescued α-synuclein-induced loss of dopaminergic neurons, a hallmark of PD, in nematodes. Alleviation of PD-related neurodegeneration by spermidine was accompanied by induction of autophagy, suggesting that this cytoprotective process may be responsible for the beneficial effects of spermidine administration.
- Published
- 2014
10. Spermidine – a novel protector against neurodegeneration in Drosophila melanogaster
- Author
-
Michael, Eva
- Published
- 2014
- Full Text
- View/download PDF
11. A new method to characterize function of the Drosophila heart by means of optical flow.
- Author
-
Moönck, Hauke, Toppe, David, Michael, Eva, Sigrist, Stephan, Richter, Vincent, Hilpert, Diana, Raccuglia, Davide, Efetova, Marina, and Schwärzel, Martin
- Subjects
DROSOPHILA ,OPTICAL flow ,VISUAL perception ,HYPERTROPHY ,CAENORHABDITIS elegans ,NEUROPLASTICITY - Abstract
The minuteness of Drosophila poses a challenge to quantify performance of its tubular heart and computer-aided analysis of its beating heart has evolved as a resilient compromise between instrumental costs and data robustness. Here, we introduce an optical flow algorithm (OFA) that continuously registers coherent movement within videos of the beating Drosophila heart and uses this information to subscribe the time course of observation with characteristic phases of cardiac contraction or relaxation. We report that the OFA combines high discriminatory power with robustness to characterize the performance of the Drosophila tubular heart using indicators from human cardiology. We provide proof of this concept using the test bed of established cardiac conditions that include the effects of ageing, knockdown of the slow repolarizing potassium channel subunit KCNQ and ras-mediated hypertrophy of the heart tube. Together, this establishes the analysis of coherent movement as a suitable indicator of qualitative changes of the heart's beating characteristics, which improves the usefulness of Drosophila as a model of cardiac diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. KILLED IN THE QUAKE MOMENTS AFTER HE RANG WIFE.
- Author
-
Neil Michael; Eva Marie Gibney
- Abstract
EARTHQUAKE victim Eoin McKenna had phoned his wife to tell her he was going shopping - just a few minutes before he was killed. [ABSTRACT FROM PUBLISHER]
- Published
- 2011
13. The secret life of our beggars.
- Author
-
Neil Michael; Eva-Marie Gibney; Shayne Phelan
- Abstract
THEY are the most publicly-recognisable face of a huge begging problem that blights the streets of our capital. Each day, Roma gypsies will position themselves at various key points — parking ticket machines, ATMs, supermarket entrances — regardless of the weather. [ABSTRACT FROM PUBLISHER]
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.